FC-GAMMA RECEPTORS IN CANCER AND INFECTIOUS-DISEASE

被引:10
作者
FANGER, MW
ERBE, DV
机构
[1] DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, DEPT MICROBIOL, HANOVER, NH 03756 USA
[2] DARTMOUTH COLL, HITCHCOCK MED CTR, DARTMOUTH MED SCH, DEPT MED, HANOVER, NH 03756 USA
关键词
CYTOTOXICITY; ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY; FC RECEPTOR; TOXOPLASMA-GONDII; DENGUE VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;
D O I
10.1007/BF02919127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Through interaction with antibody, IgG Fc receptors provide an interface between specific humoral immunity and FcgammaR-bearing host cells. FcgammaR trigger such diverse functions as immune complex clearance, phagocytosis of opsonized pathogens, reactive oxygen intermediate and enzyme secretion, and antibody-dependent cellular cytotoxicity (ADCC). Moreover, FcgammaR are the exclusive trigger molecules for tumor cell killing by human myeloid cells. Studies of FcgammaR function have been aided by the use of bispecific antibodies to link cells or pathogens to specific host cell molecules, including FcgammaR. These reagents have permitted determination of the role of FcgammaR in ADCC of the protozoan, Toxoplasma gondii, by human effector cells. This approach has also indicated that FcgammaR do not serve as entry points for viruses such as dengue virus and HIV. Taken together, these results provide insight into the utility of manipulating FcgammaR function in the therapy of cancer and infectious disease.
引用
收藏
页码:203 / 216
页数:14
相关论文
共 89 条
[11]   BLOCKADE OF CLEARANCE OF IMMUNE-COMPLEXES BY AN ANTI-FC-GAMMA-RECEPTOR MONOCLONAL-ANTIBODY [J].
CLARKSON, SB ;
KIMBERLY, RP ;
VALINSKY, JE ;
WITMER, MD ;
BUSSEL, JB ;
NACHMAN, RL ;
UNKELESS, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (02) :474-489
[12]   MACROPHAGE-TROPIC STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 UTILIZE THE CD4 RECEPTOR [J].
COLLMAN, R ;
GODFREY, B ;
CUTILLI, J ;
RHODES, A ;
HASSAN, NF ;
SWEET, R ;
DOUGLAS, SD ;
FRIEDMAN, H ;
NATHANSON, N ;
GONZALEZSCARANO, F .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4468-4476
[13]   FC-RECEPTORS FOR IGG (FC-GAMMA-RS) ON HUMAN MONOCYTES AND MACROPHAGES ARE NOT INFECTIVITY RECEPTORS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) - STUDIES USING BISPECIFIC ANTIBODIES TO TARGET HIV-1 TO VARIOUS MYELOID CELL-SURFACE MOLECULES, INCLUDING THE FC-GAMMA-R [J].
CONNOR, RI ;
DINCES, NB ;
HOWELL, AL ;
ROMETLEMONNE, JL ;
PASQUALI, JL ;
FANGER, MW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (21) :9593-9597
[14]   MONOCLONAL-ANTIBODIES FOR TREATING CANCER [J].
DILLMAN, RO .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (07) :592-603
[15]   THE EFFECT OF CYTOKINES ON THE EXPRESSION AND FUNCTION OF FC-RECEPTORS FOR IGG ON HUMAN MYELOID CELLS [J].
ERBE, DV ;
COLLINS, JE ;
SHEN, L ;
GRAZIANO, RF ;
FANGER, MW .
MOLECULAR IMMUNOLOGY, 1990, 27 (01) :57-67
[16]  
ERBE DV, 1991, J IMMUNOL, V146, P3145
[17]   CYTO-TOXICITY MEDIATED BY HUMAN FC-RECEPTORS FOR IGG [J].
FANGER, MW ;
SHEN, L ;
GRAZIANO, RF ;
GUYRE, PM .
IMMUNOLOGY TODAY, 1989, 10 (03) :92-99
[18]  
FANGER MW, 1989, CHEM IMMUNOL, V47, P214
[19]   HUMAN NEUTROPHIL FC-GAMMA-RECEPTOR DISTRIBUTION AND STRUCTURE [J].
FLEIT, HB ;
WRIGHT, SD ;
UNKELESS, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (10) :3275-3279
[20]  
FRIES LF, 1983, J IMMUNOL, V131, P1240